Dermata Therapeutics, Inc.
DRMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001853816
No open-market purchases or sales by Dermata Therapeutics, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $158.0K in total; no superinvestor holds it.
Holders of 5% or more of DRMA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Dermata Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Proehl Gerald T | 13D/A | 17.30%694.7K shares | −2.30 ppfrom 19.60% | Jan 23, 20257 filings | Feb 23, 2026 | SEC |
| Armistice Capital, LLC | 13G/A | 9.99%1.07M shares | 0.00 ppfrom 9.99% | Feb 14, 20252 filings | May 15, 2025 | SEC |
| Bigger Capital Fund L P | 13G/A | 9.89%300.1K shares | +2.46 ppfrom 7.43% | Dec 30, 20252 filings | Feb 9, 2026 | SEC |
| Van Hoose Kyri K. | 13D | 9.00%384.4K shares | New | Jun 1, 20261 filing | Jun 1, 2026 | SEC |
| Intracoastal Capital, LLC | 13G | 5.50%147.1K shares | +5.10 ppfrom 0.40% | Jan 28, 20253 filings | Jan 2, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
18 Schedule 13D and 13G filings on Dermata Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 1, 20264:34 PM ET | Van Hoose Kyri K. | 13D | 9.00%384.4K shares | New | May 27, 2026 | SEC |
| Feb 23, 20267:56 PM ET | Proehl Gerald T | 13D/A | 17.30%694.7K shares | −2.30 ppfrom 19.60% | Feb 19, 2026 | SEC |
| Feb 18, 20264:49 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%53.9K shares | 0.00 ppfrom 4.99%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20269:48 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%53.9K shares | −5.00 ppfrom 9.99%Below 5% | Dec 31, 2025 | SEC |
| Feb 9, 20265:45 PM ET | Bigger Capital Fund L Pand 6 others | 13G/A | 9.89%300.1K shares | +2.46 ppfrom 7.43% | Dec 31, 2025 | SEC |
| Feb 2, 20266:35 PM ET | Proehl Gerald T | 13D/A | 19.60%694.6K shares | −5.10 ppfrom 24.70% | Jan 29, 2026 | SEC |
| Jan 8, 20264:05 PM ET | Proehl Gerald Tand 1 other | 13D/A | 24.70%694.5K shares | +11.40 ppfrom 13.30% | Dec 23, 2025 | SEC |
| Jan 2, 20264:54 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 5.50%147.1K shares | +5.10 ppfrom 0.40% | Dec 24, 2025 | SEC |
| Dec 30, 20254:18 PM ET | Bigger Capital Fund L Pand 6 others | 13G | 7.43%197.5K shares | New | Dec 23, 2025 | SEC |
| Aug 14, 20259:08 PM ET | Armistice Capital, LLCand 1 other | 13G | 9.99%672.1K shares | New | Jun 30, 2025 | SEC |
| May 15, 20253:26 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%1.07M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| May 9, 20254:04 PM ET | Intracoastal Capital, LLCand 2 others | 13G/A | 0.40%23.3K shares | −6.30 ppfrom 6.70%Below 5% | Mar 31, 2025 | SEC |
| Apr 7, 20259:37 PM ET | Proehl Gerald Tand 1 other | 13D/A | 13.30%804.1K shares | +5.50 ppfrom 7.80% | Mar 27, 2025 | SEC |
| Apr 3, 20256:00 PM ET | Proehl Gerald Tand 1 other | 13D/A | 7.80%804.1K shares | −7.20 ppfrom 15.00% | Mar 27, 2025 | SEC |
| Feb 14, 20255:41 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%276.4K shares | – | Dec 31, 2024 | SEC |
| Feb 13, 20256:00 PM ET | Proehl Gerald Tand 1 other | 13D/A | 15.00%803.8K shares | −1.00 ppfrom 16.00% | Jan 24, 2025 | SEC |
| Jan 28, 20255:25 PM ET | Intracoastal Capital, LLCand 2 others | 13G | 6.70%262.5K shares | New | Jan 23, 2025 | SEC |
| Jan 23, 20259:54 PM ET | Proehl Gerald Tand 1 other | 13D/A | 16.00%803.8K shares | – | Jan 21, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Dermata Therapeutics, Inc. shares.
No Form 144 notices for Dermata Therapeutics, Inc. are on file.